<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725359</url>
  </required_header>
  <id_info>
    <org_study_id>AUTF ANESTHESIA</org_study_id>
    <nct_id>NCT02725359</nct_id>
  </id_info>
  <brief_title>Tizanidine and Superficial Cervical Block on Pain After Thyroidectomy</brief_title>
  <acronym>PTUSGSCB</acronym>
  <official_title>Preemptive Single Dose Tizanidine and Ultrasound Guided Superficial Cervical Block on Pain After Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroid surgery is a quite painful procedure performed in a sensitive skin area of the human
      body. Unless pain is treated adequately thyroid surgery may cause severe postoperative pain
      and discomfort for the patients.

      a2-Agonists are sympatholytic and centrally acting antihypertensive agents. In addition to
      their hypotensive effect, a2-agonists are also used in anesthetic practice for their sedative
      and analgesic effects. Tizanidine is a centrally acting a2-agonist with muscle relaxant,
      sedative and anxiolytic properties. This drug is widely used for the treatment of spasticity
      and has recently been used to treat musculoskeletal pain conditions.

      Ultrasound (US) guidance during regional anesthesia practices has been a revolutionary
      advancement to improve success and safety of regional anesthesia. Analgesic effect of US
      guidance superficial cervical plexus block (SCPB) in patients undergoing thyroid surgery has
      not been reported yet.

      The aim of this study was to evaluate the analgesic effect of preemptive oral single dose
      tizanidine and US guidance SCPB in patients undergoing elective thyroid surgery. The
      investigators hypothesis that: Tizanidine and US guided SCPB can reduce the pain scores,
      analgesic consumption, analgesic related side effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative first hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at first hour postoperatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative second hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at second hour postoperatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 4th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 4th hour postoperatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 8th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 8th hour postoperatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 12th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS)score of 0-10 (0= no pain and 10= worst imaginable pain) at 12th hour postoperatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 24th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS)score of 0-10 (0= no pain and 10= worst imaginable pain) at 24th hour postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>First 24 hours total opioid consumption</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Thyroidectomy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group Placebo (Group P) will receive placebo 1 hour before surgery and bilateral superficial cervical block with saline 10 ml each side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tizanidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group Tizanidine (Group T) will receive 6 mg tizanidine 1 hour before surgery and bilateral superficial cervical block with %0.25 bupivacaine 10ml each side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group Bupivacaine will receive placebo 1 hour before surgery and bilateral superficial cervical block with %0.25 bupivacaine 10ml each side</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Group Placebo: will receive a placebo pill 1 hour before surgery</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>Placebo pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tizanidine</intervention_name>
    <description>Group T: 6 mg tizanidine1 hour before surgery</description>
    <arm_group_label>Tizanidine</arm_group_label>
    <other_name>Sirdalud MR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Group Bupivacaine will receive USG guided SCPB with %0,25 bupivacaine bilaterally 10 ml each side</description>
    <arm_group_label>Tizanidine</arm_group_label>
    <arm_group_label>Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>USG guided SCPB with saline bilaterally 10 ml each side</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologist's physiologic state I-III patients undergoing
             thyroidectomy

        Exclusion Criteria:

          -  chronic pain

          -  bleeding disorders

          -  renal or hepatic insufficiency

          -  patients on chronic non-steroidal anti-inflammatory medications

          -  recurrent goiter

          -  emergency cases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Ahiskalioglu, Ass.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ataturk University Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ataturk University</name>
      <address>
        <city>Yakutiye</city>
        <state>Erzurum</state>
        <zip>25100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Yazicioğlu D, Caparlar C, Akkaya T, Mercan U, Kulaçoğlu H. Tizanidine for the management of acute postoperative pain after inguinal hernia repair: A placebo-controlled double-blind trial. Eur J Anaesthesiol. 2016 Mar;33(3):215-22. doi: 10.1097/EJA.0000000000000371.</citation>
    <PMID>26555871</PMID>
  </reference>
  <reference>
    <citation>Talakoub R, Abbasi S, Maghami E, Zavareh SM. The effect of oral tizanidine on postoperative pain relief after elective laparoscopic cholecystectomy. Adv Biomed Res. 2016 Feb 8;5:19. doi: 10.4103/2277-9175.175905. eCollection 2016.</citation>
    <PMID>26962521</PMID>
  </reference>
  <reference>
    <citation>Gürkan Y, Taş Z, Toker K, Solak M. Ultrasound guided bilateral cervical plexus block reduces postoperative opioid consumption following thyroid surgery. J Clin Monit Comput. 2015 Oct;29(5):579-84. doi: 10.1007/s10877-014-9635-x. Epub 2014 Oct 26.</citation>
    <PMID>25344881</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2016</study_first_submitted>
  <study_first_submitted_qc>March 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <last_update_submitted>December 19, 2016</last_update_submitted>
  <last_update_submitted_qc>December 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ali Ahiskalioglu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Thyroidectomy pain</keyword>
  <keyword>Tizanidine</keyword>
  <keyword>Postoperative analgesia</keyword>
  <keyword>Ultrasound guided Superficial cervical plexus block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Tizanidine</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

